MARC details
| 000 -LEADER |
| fixed length control field |
03968nam a2200289 i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20201006122139.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
160214s2009 enka|||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780444532947 (hbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0444532943 (hbk.) |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
EG-NcFUE |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Edition number |
22 |
| Classification number |
615.7042 |
| Item number |
S |
| 245 00 - TITLE STATEMENT |
| Title |
Side effects of drugs annual 31 : |
| Remainder of title |
a worldwide yearly survey of new data and trends in adverse drug reactions and interactions / |
| Statement of responsibility, etc |
Editor J. K Aronson. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
Amsterdam ; |
| -- |
London : |
| Name of publisher, distributor, etc |
Elsevier Science, |
| Date of publication, distribution, etc |
2009. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xli, 806 pages: |
| Other physical details |
illustartions ; |
| Dimensions |
25 cm |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| 500 ## - GENERAL NOTE |
| General note |
pharmacy bookfair2016 |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Front cover; Side effects of drugs annual 31; Copyright page; Contents; Contributors; Special reviews; Cumulative indexes of special reviews, Annuals 12-30; Index of drugs; Index of adverse effects; Table of Essays, Annuals 1-30; Classifications of adverse drug reactions; 1. EIDOS; 2. DoTS; How to use this book; THE SCOPE OF THE ANNUAL; PERIOD COVERED; SELECTION OF MATERIAL; CLASSIFICATION OF DRUGS; DRUG NAMES; SYSTEM OF TAGGING REFERENCES; INDEXES; Side Effects of Drugs Essay: MedDRA®: the Tale of a Terminology; The history of MedDra; The scope and structure of MedDra Sustaining MedDra: the MSSO and Management BoardMedDra and regulatory agencies; Applications of MedDra: coding; Applications of MedDra: data retrieval and presentation; The future of MedDra; Conclusions; Acknowledgements; References; Chapter 1. Central nervous system stimulants and drugs that suppress appetite; AMPHETAMINES; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Metamfetamine; Atomoxetine; Methylphenidate; Modafinil; METHYLXANTHINES; Caffeine; Theophylline; DRUGS THAT SUPPRESS APPETITE; Phentermine; Sibutramine; DRUGS USED IN ALZHEIMER'S DISEASE; Donepezil; Rivastigmine; REFERENCES Chapter 2. Antidepressant drugsGENERAL; SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRIs); SSRIs and suicide; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs); Venlafaxine; OTHER ANTIDEPRESSANTS; Bupropion (amfebutamone); Reboxetine; REFERENCES; Chapter 3. Lithium; REFERENCES; Chapter 4. Drugs of abuse; CANNABINOIDS; COCAINE; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Khat; OPIOID ANALGESICS; REFERENCES; Chapter 5. Hypnosedatives and anxiolytics; BENZODIAZEPINES; Alprazolam; Diazepam; Flunitrazepam; Lorazepam; Midazolam; Quazepam; Temazepam; Triazolam; OTHER HYPNOSEDATIVES Chloral hydrateZolpidem; Zopiclone; REFERENCES; Chapter 6. Antipsychotic drugs; GENERAL; INDIVIDUAL DRUGS; Amisulpride; Clozapine; Haloperidol; Olanzapine; Quetiapine; Risperidone; Sarcosine; Ziprasidone; REFERENCES; Chapter 7. Antiepileptic drugs; GENERAL; Carbamazepine; Gabapentin; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenytoin and fosphenytoin; Pregabalin; Tiagabine; Topiramate; Valproate sodium and semisodium (divalproex); Vigabatrin; Zonisamide; REFERENCES; Chapter 8. Opioid analgesics and narcotic antagonists; GENERAL; OPIOID RECEPTOR AGONISTS; Alfentanil; Codeine DextromethorphanDextropropoxyphene; Diamorphine (heroin); Fentanyl; Frakefamide; Hydrocodone; Hydromorphone; Methadone; Morphine; Morphine-6-glucuronide; Oxycodone; Oxymorphone; Papaverine; Pethidine (meperidine); Remifentanil; Sufentanil; Tramadol; PARTIAL OPIOID RECEPTOR AGONISTS; Buprenorphine; Butorphanol; OPIOID RECEPTOR ANTAGONISTS; Naloxone; Naltrexone; REFERENCES; Chapter 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout; ANILINE DERIVATIVES; Paracetamol (acetaminophen) and combinations; NON-STEROIDAL ANTIINFLAMMATORY DRUGS; ARYLALKANOIC ACID DERIVATIVES |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Side effects |
| Form subdivision |
Periodicals. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmacology |
| Form subdivision |
Periodicals. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug interactions. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Aronson, J. K. |
| Relator term |
editor. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1835">http://repository.fue.edu.eg/xmlui/handle/123456789/1835</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |